Infectious Diseases Research Collaboration
University of California San Francisco
London School of Hygiene & Tropical Medicine
The Bristol-Myers Squibb Research and Development organization (R&D) is one of the world's most innovative, productive, and respected scientific research organizations. Our purpose is to discover and develop innovative, cost-effective medicines that address significant unmet medical needs, enhance and extend human life. Moreover, R&D is an extraordinary area in which to work—thanks to 7,000 employees’ remarkable talent, dedication, and passion for using science to improve human health.
The Sandler Center for Basic Research in Parasitic Diseases (SCBRPD) establishes a consortium of Core laboratories to support development of new drugs for global parasitic diseases largely ignored by the pharmaceutical industry. Our specific focus is to provide a drug development pipeline from target discovery to clinical trials to fill a gap normally addressed in the industrial sector.
Medicines for Malaria Venture (MMV) A nonprofit organization created to discover develop and deliver new anti-malarial drugs through effective public-private partnerships. Our vision is a world in which affordable drugs will help eliminate the devastating effects of malaria and help protect the billions of people, especially children and pregnant women, at risk of this terrible disease.
The GlaxoSmithKline (GSK) African Malaria Partnership. Young children and pregnant women are particularly vulnerable to malaria. Although this disease can easily and inexpensively be prevented and treated, over one million African children die from the disease each year.